Virus-like antigen display for cancer vaccine development, what is the potential?

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

(2018) Aimée R. Kreimer et al.   VACCINE

Virus-like particle display of HER2 induces potent anti-cancer responses

(2018) Arianna Palladini et al.   OncoImmunology

Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response

(2017) Atefeh Arab et al.   IMMUNOLOGIC RESEARCH

Virus like particles as a platform for cancer vaccine development

(2017) Hui Kian Ong et al.   PeerJ

A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer

(2016) Giuseppe Curigliano et al.   BREAST CANCER RESEARCH AND TREATMENT

Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma

(2016) N. J. Mason et al.   CLINICAL CANCER RESEARCH

Bacterial superglue enables easy development of efficient virus-like particle based vaccines

(2016) Susan Thrane et al.   JOURNAL OF NANOBIOTECHNOLOGY

Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform

(2016) Josef Singer et al.   OncoImmunology

Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity

(2015) Jaina M. Patel et al.   BIOTECHNOLOGY AND BIOENGINEERING

Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

(2014) A. Makkouk et al.   CANCER RESEARCH

Hypersensitivity Reactions to Biologic Agents

(2014) Alessandra Vultaggio et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Active immunotherapy for chronic diseases

(2013) Martin F. Bachmann et al.   VACCINE

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin

(2012) B. Zakeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles

(2011) Seyed Amir Jalali et al.   Nanomedicine-Nanotechnology Biology and Medicine

In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations

(2010) A. Palladini et al.   CANCER RESEARCH

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

(2009) Ursula Wiedermann et al.   BREAST CANCER RESEARCH AND TREATMENT

Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

(2008) G. E. Peoples et al.   CLINICAL CANCER RESEARCH

Murine pneumotropic virus chimeric Her2/neuvirus-like particles as prophylactic and therapeutic vaccines against Her2/neuexpressing tumors

(2008) Kalle Andreasson et al.   INTERNATIONAL JOURNAL OF CANCER